Document is current
Any future updates will be listed below
-
Authors
Gupta, Rishi K. https://orcid.org/0000-0002-6257-1285
Calderwood, Claire J.
Yavlinsky, Alexei
Krutikov, Maria https://orcid.org/0000-0002-3982-642X
Quartagno, Matteo
Aichelburg, Maximilian C.
Altet, Neus
Diel, Roland
Dobler, Claudia C. https://orcid.org/0000-0002-5460-0189
Dominguez, Jose
Doyle, Joseph S.
Erkens, Connie
Geis, Steffen
Haldar, Pranabashis https://orcid.org/0000-0002-1572-5421
Hauri, Anja M. https://orcid.org/0000-0001-6569-0768
Hermansen, Thomas
Johnston, James C.
Lange, Christoph
Lange, Berit
van Leth, Frank https://orcid.org/0000-0002-5490-8968
Muñoz, Laura
Roder, Christine
Romanowski, Kamila
Roth, David
Sester, Martina https://orcid.org/0000-0001-5482-0002
Sloot, Rosa
Sotgiu, Giovanni https://orcid.org/0000-0002-1600-4474
Woltmann, Gerrit https://orcid.org/0000-0002-9253-6034
Yoshiyama, Takashi
Zellweger, Jean-Pierre
Zenner, Dominik
Aldridge, Robert W.
Copas, Andrew
Rangaka, Molebogeng X.
Lipman, Marc
Noursadeghi, Mahdad https://orcid.org/0000-0002-4774-0853
Abubakar, Ibrahim https://orcid.org/0000-0002-0370-1430
-
Funding
Funding for this research was provided by:
DH | National Institute for Health Research (DRF-2018-11-ST2-004, SRF-2011-04-001, NF-SI-0616-10037)
Department of Health | National Health and Medical Research Council
Deutsches Zentrum für Infektionsforschung
Wellcome Trust (207511/Z/17/Z)
- License Information
-
More Information
Article History
Received: 4 March 2020
Accepted: 26 August 2020
First Online: 19 October 2020
Competing interests
: J.S.D.ʼs institution receives investigator-initiated research grants and consultancy income from Gilead Sciences, AbbVie, Bristol Myers Squibb and Merck. The Burnet Institute receives funding from the Victorian Government Operational Infrastructure Fund. C.L. reports honoraria from Chiesi, Gilead, Insmed, Janssen, Lucane, Novartis, Oxoid, Berlin Chemie (for participation at sponsored symposia) and Oxford Immunotec (to attend a scientific advisory board meeting), all outside of the submitted work. M.S. reports receipt of test kits free of charge from Qiagen and from Oxford Immunotec for investigator-initiated research projects. I.A. reports receiving test kits free of charge from Qiagen for an investigator-initiated research project<sup>25</sup>. C.E. reports receiving test kits free of charge from Qiagen for investigator-initiated research projects outside of the submitted work. The authors declare no other conflicts of interest.
